Making sure the technology works is only part of the formula for a successful spin-out. Business sense and collaboration with potential customers are also critical
Concerns about job security and a relentless lifestyle are holding back would-be biotech entrepreneurs. Academics need to be shown the fun and energy of being in the start-up world says Kevin Johnson of Index Ventures
Venture capital is the driving force of much entrepreneurial activity and Europe needs to look to the US role model to understand how it can promote and develop its venture capital sector, says a new report
After the turbulence of credit crunch and recession, US venture capitalists regained some confidence in 2010. More money is becoming available for seed investments and start-ups, and the words Initial, Public and Offering are creeping back into the lexicon
Index Ventures raised $400 million dollars in its last fund, of which about half will be invested in life science start-ups. Senior partner, Francesco de Rubertis says personalised medicine will take a large share of this.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.